Team:Bielefeld-Germany/Biosafety/Safety-Form

From 2013.igem.org

(Difference between revisions)
 
Line 3: Line 3:
__NOTOC__
__NOTOC__
 +
<div id=globalwrapper style="padding-left:20px; padding-right:20px">
<div id=globalwrapper style="padding-left:20px; padding-right:20px">

Latest revision as of 00:46, 5 October 2013



Biosafety Form

Basic Safety Questions for iGEM 2013


  • 1. Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:


Table of the chassis organisms we use for our project.



  • 2. Highest Risk Group Listed:
    • The highest risk group is one.



  • 3. List and describe all new or modified coding regions you will be using in your project.


Table of the coding regions we use in our project.



  • 4. Do the biological materials used in your lab work pose any of the following risks? Please describe.
    • a. Risks to the safety and health of team members or others working in the lab?
      • see 1)


    • b. Risks to the safety and health of the general public, if released by design or by accident?
      • No. All our strains are based on E. coli K12.


    • c. Risks to the environment, if released by design or by accident?
      • No. All our strains are based on E. coli K12.


    • d. Risks to security through malicious misuse by individuals, groups, or countries?
      • No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse.



  • 5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?
    • If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences.



  • 6. Does your project include any design features to address safety risks?
    • Yes it includes a kill switch and an especially safe auxotrophic chassis.



  • 7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.
    • All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.



  • 8. Under what biosafety provisions will / do you work?
    • a. Please provide a link to your institution biosafety guidelines.
      • Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]



Safety forms were approved on October 2nd, 2013 by the iGEM Safety Committee.



Contents